Three tumors were from patients who developed metastatic disease (E205, PC, EPAS1; E206, PC, EPAS1; E235, PC, MAML3-fusion), and two tumors had locally invasive features (E007, TMEM127; E025, AT-PG, SDHA). This evidence concerns the gene EPAS1 and metastatic neoplasm.